TXNIP (1 site) has consistently emerged as the most significant gene associated with T2D in previous EWAS studies [29] due to its role in regulating pancreatic β-cells production and survival [30] and has arisen as a novel potential therapeutic target in diabetes mellitus and its complications [31]. This evidence concerns the gene TXNIP and type 2 diabetes mellitus.